Ropeginterferon Alfa-2b vs Standard Therapy for Polycythemia Vera
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Ropeginterferon Alfa-2b Versus Standard Therapy for Polycythaemia Vera (PROUD-PV and CONTINUATION-PV): A Randomised, Non-Inferiority, Phase 3 Trial and Its Extension Study
Lancet Haematol 2020 Jan 31;[EPub Ahead of Print], H Gisslinger, C Klade, P Georgiev, D Krochmalczyk, L Gercheva-Kyuchukova, M Egyed, V Rossiev, P Dulicek, A Illes, H Pylypenko, L Sivcheva, J Mayer, V Yablokova, K Krejcy, B Grohmann-Izay, HC Hasselbalch, R Kralovics, JJ KiladjianFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.